Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial

Phase 4 Terminated 5 enrolled University of California, San Francisco

RandomizedParallel-groupOpen-labelTreatment

Summary

Open-label randomized clinical trial assessing the efficacy of Metformin versus Vitamin D in improving symptoms of depressed mood in polycystic ovary syndrome.

Timeline

Start: 2017-12-12
Primary completion: 2019-09-01
Completion: 2019-09-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Metformin	Small molecule	1000 mg	Oral
Subject	Vitamin D	Other / unclassified	5000 iu	Oral

Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial

Summary

Timeline

Drugs

Indications